Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) was the target of a large decline in short interest in September. As of September 30th, there was short interest totaling 8,533 shares, a decline of 67.4% from the September 15th total of 26,201 shares. Currently, 0.4% of the company’s stock are short sold. Based on an average daily volume of 8,524 shares, the short-interest ratio is currently 1.0 days.
Institutional Trading of Innovator IBD 50 ETF
Hedge funds have recently added to or reduced their stakes in the business. Guardian Wealth Advisors LLC NC purchased a new position in Innovator IBD 50 ETF during the 2nd quarter valued at about $507,000. Kraematon Investment Advisors Inc. bought a new stake in shares of Innovator IBD 50 ETF in the 2nd quarter valued at about $1,021,000. Concurrent Investment Advisors LLC raised its holdings in shares of Innovator IBD 50 ETF by 11.1% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock valued at $3,349,000 after purchasing an additional 6,321 shares in the last quarter. KFG Wealth Management LLC purchased a new stake in shares of Innovator IBD 50 ETF in the 2nd quarter worth approximately $201,000. Finally, WorthPointe LLC lifted its position in shares of Innovator IBD 50 ETF by 18.3% in the 2nd quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock worth $1,295,000 after purchasing an additional 3,771 shares during the period.
Innovator IBD 50 ETF Trading Down 1.5%
Shares of FFTY traded down $0.55 during midday trading on Monday, reaching $35.24. 3,643 shares of the stock were exchanged, compared to its average volume of 51,512. Innovator IBD 50 ETF has a 52 week low of $31.61 and a 52 week high of $44.08. The company’s 50 day moving average is $36.11 and its two-hundred day moving average is $37.94. The company has a market capitalization of $68.72 million, a P/E ratio of 30.34 and a beta of 1.48.
Innovator IBD 50 ETF Company Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Further Reading
- Five stocks we like better than Innovator IBD 50 ETF
- Salesforce Just Got a Rare Double Upgrade—What Changed?
- OpenAI’s Revenue Scare Could Be a Big Opportunity for Investors
- China Still Dominates Rare Earths—These 3 U.S. Companies Could Benefit
- 3 REITs That May Win in a Higher Interest Rate Environment
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
